CSBTF (Kuros Biosciences) Days Sales Outstanding : 45.22 (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Kuros Biosciences Days Sales Outstanding?

Kuros Biosciences's average Accounts Receivable for the six months ended in Jun. 2024 was $8.83 Mil. Kuros Biosciences's Revenue for the six months ended in Jun. 2024 was $35.63 Mil. Hence, Kuros Biosciences's Days Sales Outstanding for the six months ended in Jun. 2024 was 45.22.

The historical rank and industry rank for Kuros Biosciences's Days Sales Outstanding or its related term are showing as below:

CSBTF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 32.49 Med: 62.37 Max: 157.89
Current: 45.68

During the past 13 years, Kuros Biosciences's highest Days Sales Outstanding was 157.89. The lowest was 32.49. And the median was 62.37.

CSBTF's Days Sales Outstanding is ranked better than
77.37% of 813 companies
in the Medical Devices & Instruments industry
Industry Median: 65.14 vs CSBTF: 45.68

Kuros Biosciences's Days Sales Outstanding declined from Jun. 2023 (48.83) to Jun. 2024 (45.22).

Kuros Biosciences Days Sales Outstanding Historical Data

The historical data trend for Kuros Biosciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kuros Biosciences Days Sales Outstanding Chart

Kuros Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

69.19

77.80

36.52

45.94

49.08

Kuros Biosciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial															79.74	118.95	48.83	45.88	45.22

Competitive Comparison of Kuros Biosciences's Days Sales Outstanding

For the Medical Devices subindustry, Kuros Biosciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kuros Biosciences's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kuros Biosciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Kuros Biosciences's Days Sales Outstanding falls into.

Kuros Biosciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Kuros Biosciences's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3.024	+	7.413)	/	2 )	/	38.811	*	365
=	5.2185					/	38.811	*	365
=	49.08

Kuros Biosciences's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (7.413	+	10.243)	/	2 )	/	35.628	*	365 / 2
=	8.828					/	35.628	*	365 / 2
=	45.22

Kuros Biosciences (OTCPK:CSBTF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Kuros Biosciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Kuros Biosciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Kuros Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kuros Biosciences Ltd (OTCPK:CSBTF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

KURNz:UK 0RHR:UK KURN:Switzerland

Address

Wagistrasse 25, Schlieren, Zurich, CHE, 8952

Website

https://www.kurosbio.com

Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.